In a significant leap forward, Australia's National Immunisation Program (NIP) is set to introduce the recombinant zoster vaccine (RZV), known commercially as Shingrix, replacing the less potent Zostavax.
Read more
Though AI often makes headlines in popular culture, its practical applications in medicine are both scary, groundbreaking and transformative.
Read more
Following recent encouraging results from the SURPASS clinical trial programme, Tirzepatide has reached the pivotal milestone of new drug application submissions to the FDA and TGA.
Read more
Anticoagulants, or blood thinners, play a crucial role in reducing the natural coagulation capabilities of the blood. While clotting is an essential physiological response to prevent excessive bleeding, certain medical conditions necessitate the slowing down of this process.
Read more
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that is increasingly recognised not only in childhood but also in adulthood.
Read more
A 32-year-old Indigenous woman from Far North Queensland with poorly controlled type 2 diabetes and no recent travel history, presented to a local clinic with a day-old history of painful swallowing.
Read more
In a world where voice-controlled technology continues to rise in popularity, practical solutions for individuals with hearing impairments remain scarce.
Read more
As we find ourselves grappling with yet another twist in the global pandemic, a new Covid-19 subvariant, christened 'Arcturus', has surfaced in Australia.
Read more
As mounting pressures grow in mainstream media, Australian health professionals eagerly await the Therapeutic Goods Administration's (TGA) recommendations on vaping laws.
Read more
In late 2022, the Therapeutic Goods Administration (TGA) published an interim decision to reduce the maximum pack size for standard and modified release (MR) paracetamol products sold in supermarkets and convenience stores around Australia.
Read more
